Impact of pathognomonic genetic alterations on the prognosis of papillary thyroid carcinoma. ESES vienna presentation (Q38415602)

2 September 2017

title

Impact of pathognomonic genetic alterations on the prognosis of papillary thyroid carcinoma. ESES vienna presentation (English)

1 reference

2 September 2017

Thomas J Musholt

1

1 reference

2 September 2017

Sonja Schönefeld

2

1 reference

2 September 2017

Christina H Schwarz

3

1 reference

2 September 2017

Felix M Watzka

4

1 reference

2 September 2017

Petra B Musholt

5

1 reference

2 September 2017

Christian Fottner

6

1 reference

2 September 2017

Matthias M Weber

7

1 reference

2 September 2017

Erik Springer

8

1 reference

2 September 2017

Arno Schad

9

1 reference

2 September 2017

language of work or name

English

0 references

publication date

18 July 2010

1 reference

Langenbeck's Archives of Surgery

2 September 2017

published in

1 reference

2 September 2017

volume

395

1 reference

2 September 2017

issue

7

1 reference

2 September 2017

page(s)

877-883

1 reference

Potent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinoma

2 September 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00423-010-0682-6

High prevalence of BRAF mutation in a Brazilian cohort of patients with sporadic papillary thyroid carcinomas: correlation with more aggressive phenotype and decreased expression of iodide-metabolizing genes.

21 January 2018

1 reference

12 December 2020

Prognostic significance of RET and NTRK1 rearrangements in sporadic papillary thyroid carcinoma

1 reference

12 December 2020

RET rearrangements in archival oxyphilic thyroid tumors: new insights in tumorigenesis and classification of Hürthle cell carcinomas?

1 reference

12 December 2020

Clinical and pathological features and the BRAF(V600E) mutation in patients with papillary thyroid carcinoma with and without concurrent Hashimoto thyroiditis

1 reference

12 December 2020

BRAF mutation in papillary thyroid carcinoma: pathogenic role and clinical implications

1 reference

12 December 2020

Analysis of differential BRAF(V600E) mutational status in high aggressive papillary thyroid microcarcinoma.

1 reference

12 December 2020

Clinicopathologic significance of BRAF V600E mutation in papillary carcinomas of the thyroid: a meta-analysis

1 reference

12 December 2020

RET activation and clinicopathologic features in poorly differentiated thyroid tumors

1 reference

12 December 2020

RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes

1 reference

12 December 2020

Molecular profile of hyalinizing trabecular tumours of the thyroid: high prevalence of RET/PTC rearrangements and absence of B-raf and N-ras point mutations.

1 reference

12 December 2020

High rate of BRAF and RET/PTC dual mutations associated with recurrent papillary thyroid carcinoma

1 reference

12 December 2020

Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma.

1 reference

12 December 2020

Multiple genetic alterations in papillary thyroid cancer are associated with younger age at presentation.

1 reference

12 December 2020

Analysis of differential BRAF(V600E) mutational status in multifocal papillary thyroid carcinoma: evidence of independent clonal origin in distinct tumor foci.

1 reference

12 December 2020

The prevalence and prognostic value of BRAF mutation in thyroid cancer

1 reference

12 December 2020

BRAF mutation in papillary thyroid carcinoma in a Japanese population: its lack of correlation with high-risk clinicopathological features and disease-free survival of patients

1 reference

12 December 2020

BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study

1 reference

12 December 2020

Correlation between B-RAFV600E mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature.

1 reference

12 December 2020

Association of high iodine intake with the T1799A BRAF mutation in papillary thyroid cancer.

1 reference

12 December 2020

The BRAFV600E oncogene induces transforming growth factor beta secretion leading to sodium iodide symporter repression and increased malignancy in thyroid cancer

1 reference

12 December 2020

Detection of BRAF mutation in thyroid papillary carcinomas by mutant allele-specific PCR amplification (MASA).

1 reference

12 December 2020

BRAF Mutations in Papillary Thyroid Carcinomas Inhibit Genes Involved in Iodine Metabolism

1 reference

12 December 2020

Rearrangements of RET and NTRK1 tyrosine kinase receptors in papillary thyroid carcinomas.

1 reference

12 December 2020

Detection of RET/PTC, TRK and BRAF mutations in preoperative diagnosis of thyroid nodules with indeterminate cytological findings

1 reference

12 December 2020

BRAFMutations Are Not a Major Event in Post-Chernobyl Childhood Thyroid Carcinomas

1 reference

12 December 2020

Expression of iodine metabolism genes in human thyroid tissues: evidence for age and BRAFV600E mutation dependency

1 reference

12 December 2020

10.1007/S00423-010-0682-6

Identifiers

DOI

1 reference

2 September 2017

1 reference